Demchuk AM - Search Results

1

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.

Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, von Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, Khatri P, Spilker J, Palesch YY, Broderick JP; IMS III Investigators. Tomsick TA, et al. Among authors: demchuk am. J Neurointerv Surg. 2015 Nov;7(11):795-802. doi: 10.1136/neurintsurg-2014-011318. Epub 2014 Oct 23. J Neurointerv Surg. 2015. PMID: 25342652 Clinical Trial.

2

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.

Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Hill MD, et al. Among authors: demchuk am. CMAJ. 2000 May 2;162(9):1281-4. CMAJ. 2000. PMID: 10813008 Free PMC article.

3

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.

Hill MD, Barber PA, Demchuk AM, Sevick RJ, Newcommon NJ, Green T, Buchan AM. Hill MD, et al. Among authors: demchuk am. CMAJ. 2000 May 30;162(11):1589-93. CMAJ. 2000. PMID: 10862236 Free PMC article.

4

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.

Hill MD, Barber PA, Demchuk AM, Buchan AM. Hill MD, et al. Among authors: demchuk am. BMJ. 2000 Jul 29;321(7256):299. BMJ. 2000. PMID: 10979695 Free PMC article. No abstract available.

5

Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke?

Barber PA, Hill MD, Demchuk AM, Buchan AM. Barber PA, et al. Among authors: demchuk am. Can J Neurol Sci. 2000 Nov;27(4):283-7. doi: 10.1017/s0317167100001001. Can J Neurol Sci. 2000. PMID: 11097516 Review.

6

Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia.

Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Barber PA, et al. Among authors: demchuk am. Stroke. 2001 Jan;32(1):84-8. doi: 10.1161/01.str.32.1.84. Stroke. 2001. PMID: 11136919 Clinical Trial.

7

Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.

Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Demchuk AM, et al. Stroke. 2001 Jan;32(1):89-93. doi: 10.1161/01.str.32.1.89. Stroke. 2001. PMID: 11136920 Clinical Trial.

8

Symptomatic hemorrhage after alteplase therapy not due to silent ischemia.

Hill MD, Barber PA, Demchuk AM, Sevick RJ, Frayne R, Buchan AM. Hill MD, et al. Among authors: demchuk am. BMC Neurol. 2001 Dec 18;1:1. doi: 10.1186/1471-2377-1-1. Epub 2001 Dec 18. BMC Neurol. 2001. PMID: 11208259 Free PMC article.

9

Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.

Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Barber PA, et al. Among authors: demchuk am. Neurology. 2001 Apr 24;56(8):1015-20. doi: 10.1212/wnl.56.8.1015. Neurology. 2001. PMID: 11320171

10

Predictors of good outcome after intravenous tPA for acute ischemic stroke.

Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, Levine SR; mMulticentre tPA Stroke Survey Group. Demchuk AM, et al. Neurology. 2001 Aug 14;57(3):474-80. doi: 10.1212/wnl.57.3.474. Neurology. 2001. PMID: 11502916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters